Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

Journal of Hepatology

Volumn 53, Issue 5, 2010, Pages 849-855

  Gupta, Ankur ^a   Dhiman, Radha K ^a   Kumari, Savita ^a   Rana, Satyavati ^a   Agarwal, Ritesh ^a   Duseja, Ajay ^a   Chawla, Yogesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatic encephalopathy; Minimal hepatic encephalopathy; Probiotics; Small intestinal bacterial overgrowth

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BREATH ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EDUCATIONAL STATUS; FEMALE; GASTROINTESTINAL TRANSIT; HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; SCORING SYSTEM; SCREENING; SMALL INTESTINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL TRANSIT; HEPATIC ENCEPHALOPATHY; HUMANS; INTESTINE, SMALL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE;

EID: 77957345947     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.017     Document Type: Article

References (48)

1. P. Ferenci, A. Lockwood, K. Mullen, R. Tarter, K. Weissenborn, and A.T. Blei Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 2002 716 721
2. S. Prasad, R.K. Dhiman, A. Duseja, Y.K. Chawla, A. Sharma, and R. Agrawal Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy Hepatology 45 2007 549 559
3. A. Das, R.K. Dhiman, V.A. Saraswat, M. Verma, and S.R. Naik Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis J Gastroenterol Hepatol 16 2001 531 535
4. M. Romero-Gomez, F. Boza, M.S. Garcia-Valdecasas, E. Garcia, and J. Aguilar-Reina Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy Am J Gastroenterol 96 2001 2718 2723
5. A.H. Lockwood, E.W. Yap, and W.H. Wong Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy J Cereb Blood Flow Metab 11 1991 337 341
6. R.K. Dhiman, and Y.K. Chawla Minimal hepatic encephalopathy Indian J Gastroenterol 28 2009 5 16
7. T.M. Bauer, B. Steinbrückner, F.E. Brinkmann, A.K. Ditzen, H. Schwacha, and J.J. Aponte Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis Am J Gastroenterol 96 2001 2962 2967
8. C.S. Chang, G.H. Chen, H.C. Lien, and H.Z. Yeh Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 28 1998 1187 1190
9. M.H. Floch, J. Katz, and H.O. Conn Qualitative and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis. Gastroenterology. 1970 Jul;59(1):70-5.anastomosis Gastroenterology 59 1970 70 75
10. J. Chesta, C. Defilippi, and C. Defilippi Abnormalities in proximal small bowel motility in patients with cirrhosis Hepatology 17 1993 828 832
11. J.J. Stewart, H.D. Battarbee, G.E. Farrar, and K.W. Betzing Intestinal myoelectrical activity and transit time in chronic portal hypertension Am J Physiol 263 1992 G474 479
12. R. Sadik, H. Abrahamsson, E. Björnsson, A. Gunnarsdottir, and P.O. Stotzer Etiology of portal hypertension may influence gastrointestinal transit Scand J Gastroenterol 38 2003 1039 1044
13. S.M. Riordan, N. Skinner, A. Nagree, H. McCallum, C.J. McIver, and J. Kurtovic Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 2003 1154 1164
14. A.M. Madrid, J. Brahm, E. Buckel, G. Silva, and C. Defilippi Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients Am J Gastroenterol 92 1997 1044 1045
15. Q. Liu, Z.P. Duan, D.K. Ha, S. Bengmark, J. Kurtovic, and S.M. Riordan Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 2004 1441 1449
16. J.S. Bajaj, K. Saeian, K.M. Christensen, M. Hafeezullah, R.R. Varma, and J. Franco Probiotic yogurt for the treatment of minimal hepatic encephalopathy Am J Gastroenterol 103 2008 1707 1715
17. V.V. Mittal, P. Sharma, B.C. Sharma, and S. Sarin Treatment of minimal hepatic encephalopathy: a randomised controlled trial comparing lactulose, probiotics and L ornithine L aspartate with placebo Hepatology 50 suppl 2009 471A
18. K. Weissenborn, J.C. Ennen, H. Schomerus, N. Rückert, and H. Hecker Neuropsychological characterization of hepatic encephalopathy J Hepatol 34 2001 768 773
19. M. Romero-Gómez, J. Córdoba, R. Jover, J.A. del Olmo, M. Ramírez, and R. Rey Value of the critical flicker frequency in patients with minimal hepatic encephalopathy Hepatology 45 2007 879 885
20. R.K. Dhiman, R. Kurmi, K.K. Thumburu, S.H. Venkataramarao, R. Agarwal, and A. Duseja Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver Dig Dis Sci 55 2010 2381 2390
21. R.K. Dhiman, V.A. Saraswat, M. Verma, and S.R. Naik Figure connection test: a universal test for assessment of mental state J Gastroenterol Hepatol 10 1995 14 23
22. P. Kerlin, and L. Wong Breath hydrogen testing in bacterial overgrowth of small intestine Gastroenterology 95 1988 982 988
23. I.H. Anderson, A.S. Levine, and M.D. Levitt Incomplete absorption of the carbohydrate in all-purpose wheat flour N Engl J Med 304 1981 891 892
24. D.G. Thompson, P. Binfield, A. De Belder, J. O'Brien, S. Warren, and M. Wilson Extra-intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease Gut 26 1985 1349 1352
25. S. Sarno, L.P. Erasmas, M. Haslbeck, and R. Holzl Oro-caecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus Ital J Gastroenterol 25 1993 490 496
26. R. Newcombe Two-sided confidence intervals for the single proportion: a comparative evaluation of seven methods Stat Med 17 1998 857 872
27. A.S. McIntyre, D.G. Thompson, S. Day, W.R. Burnham, and E.R. Walker Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway Gut 33 1992 1062 1070
28. M. Pérez-Paramo, J. Muñoz, A. Albillos, I. Freile, F. Portero, and M. Santos Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43 48
29. U. Spengler, F. Stellaard, G. Ruckdeschel, C. Scheurlen, and W. Kruis Small intestinal transit, bacterial growth, and bowel habits in diabetes mellitus Pancreas 4 1989 65 70
30. L. Cuoco, M. Montalto, R.A. Jorizzo, L. Santarelli, F. Arancio, and G. Cammarota Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics Hepatogastroenterology 49 2002 1582 1586
31. S.A. Gunnarsdottir, R. Sadik, S. Shev, M. Simrén, H. Sjövall, and P.O. Stotzer Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension Am J Gastroenterol 98 2003 1362 1370
32. F. Casafont Morencos, G. s Castaño, L. Martín Ramos, M.J. López Arias, F. Ledesma, and F. Pons Romero Small bowel bacterial overgrowth in patients with alcoholic cirrhosis Dig Dis Sci 41 1996 552 556
33. C. Pande, A. Kumar, and S.K. Sarin Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease Aliment Pharmacol Ther 29 2009 1273 1281
34. A.M. Madrid, F. Cumsille, and C. Defilippi Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease Dig Dis Sci 42 1997 738 742
35. E. Kalaitzakis, R. Sadik, J. Juul Holst, L. Öhman, and E. Björnsson Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis Clin Gastroenterol Hepatol 7 2009 246 352
36. D.H. Van Thiel, S. Fagiuoli, H.I. Wright, M.C. Chien, and J.S. Gavaler Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment Hepatology 19 1994 67 71
37. J.F. Fleckenstein, S. Frank, and P.J. Thuluvath Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease Hepatology 23 1996 471 475
38. M.T. Hendrickse, and D.R. Triger Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function J Hepatol 16 1992 177 183
39. P.J. Thuluvath, and D.R. Triger Autonomic neuropathy and chronic liver disease Q J Med 72 1989 737 747
40. A. Maheshwari, and P.J. Thuluvath Autonomic neuropathy may be associated with delayed oro-cecal transit time in patients with cirrhosis Auton Neurosci 118 2005 135 139
41. A. Maheshwari, A. Thomas, and P.J. Thuluvath Patients with autonomic neuropathy are more likely to develop hepatic encephalopathy Dig Dis Sci 49 2004 1584 1588
42. J.A. Reilly, E.M.M. Quigley, C. Forst, and L.F. Rikkers Small intestinal transit in the portal hypertensive rat Gastroenterology 100 1991 670 674
43. D.L. Shawcross, G. Wright, S.W. Olde Damink, and R. Jalan Role of ammonia and inflammation in minimal hepatic encephalopathy Metab Brain Dis 22 2007 125 138
44. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130 (2)(Suppl. 1):S78-S90.
45. S.F. Solga Probiotics can treat hepatic encephalopathy Med. Hypotheses 61 2003 307 313
46. X.S. Fu, and F. Jiang Cisapride decreasing oro-cecal transit time in patients with non-alcoholic steatohepatitis Hepatobiliary Pancreat Dis Int 5 2006 534 537
47. A.M. Madrid, C. Hurtado, M. Venegas, F. Cumsille, and C. Defilippi Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function Am J Gastroenterol 96 2001 1251 1255
48. A. Soza, A. Riquelme, and R. González Increased orocecal transit time in patients with non-alcoholic fatty liver disease Dig Dis Sci. 50 2005 1136 1140